Navigation Links
Call for Applications: The Amgen Award for Science Teaching Excellence
Date:11/3/2008

34 Outstanding Teachers Will Be Recognized in Communities Where Amgen

Operates

THOUSAND OAKS, Calif., Nov. 3 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that it now invites applications for its 18th annual Amgen Award for Science Teaching Excellence (AASTE). This award is designed to recognize and honor extraordinary science teachers at the K-12 level who significantly impact their students through exemplary science teaching and who achieve demonstrated results in student learning in communities where Amgen operates.

With a longstanding commitment to science education, Amgen established the teacher awards program to promote and encourage science excellence in public and private schools. Since the program's inception in 1992, Amgen has awarded more than $2 million to educators who have made exceptional science-teaching contributions and who have significantly impacted the lives of their students.

Amgen is expanding its program this year, and will honor a total of 34 teachers in California, Colorado, Kentucky, Massachusetts, Puerto Rico, Rhode Island, Washington and Canada (Alberta, British Columbia, Ontario and Quebec). In addition, a new streamlined web-based application will be available this year.

"At Amgen, we believe that extraordinary teachers can inspire a passion for science," said Phyllis Piano, vice president, Corporate Communications and Philanthropy at Amgen. "Since the beginning of the AASTE program more than 200 teachers have been honored for their dedication, and we look forward to celebrating the achievements of this year's recipients."

The 34 selected winners within the United States, Puerto Rico and Canada will receive the following benefits:

-- An unrestricted cash award of $5,000USD or $5,000CAD; and

-- A restricted $5,000USD or $5,000CAD cash grant to the recipient's school for the expansion or enhancement of a school science program, science resources, or the professional development of the school's science teachers.

Applicants are required to submit an innovative lesson plan that they have successfully incorporated into their classroom and that can be shared with other teachers. A panel of independent judges will select the winners based on the following criteria: creativity and effectiveness of teaching methods; innovative lesson plan; and the plan for the use of grant money to improve science education resources in their schools.

A select number of the lesson plans submitted by 2009 AASTE Award winners will be posted to Amgen's Website, with the intent that other teachers will benefit from these innovative materials. Select lesson plans from 2007 and 2008 AASTE Award winners are available for download at no cost; educators are encouraged to review and implement any of these plans into their own curriculum.

Those interested in applying should visit http://www.amgen.com/citizenship/aaste.html for more information. The application can be completed online and French and Spanish applications are available in PDF format. Applications must be submitted by Feb. 2, 2009 to be valid. Winners will be notified in between April and June 2009.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit http://www.amgen.com.

CONTACT: Amgen, Thousand Oaks

Kristen Davis, (805) 447-3008 (media) (Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Amgens Third Quarter 2008 Adjusted Earnings Per Share Increased 14 Percent to $1.23
2. Amgen Announces Webcast of 2008 Third Quarter Financial Results
3. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
4. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
5. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
6. Entry of Biogenerics and Decreasing Use of Amgens Epogen and Johnson & Johnsons Procrit Will Cause a $2.8 Billion Decline in the Drug Market for Chemotherapy-Induced Anemia by 2016
7. More Than 230 Cyclists to Ride in Amgen California Coast Classic Bike Tour to Raise $1.3 Million for Arthritis Foundation
8. Amgen and Genentech Brace Themselves for Heavy Pressure From Biogenerics Manufacturers
9. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
10. PAREXEL Partners with Glenmark to Win the Good Clinical Practice Journal Award for Most Innovative Patient Recruitment Strategy
11. Abbotts XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... 1, 2016   SurePure, Inc. (OTCQB: SURP) ... the Company has concluded an agreement with Tamarack Biotics ... 90-day period to acquire units of the Company,s patented ... 3.7 million.  Concurrently with the option, ... which Tamarack will seek regulatory approvals in ...
(Date:11/30/2016)... 30, 2016 The global Pyrogen ... hold a dominant share in the overall market. The ... Inc., and Merck KGaA, held a lion,s share of ... Research observes that these companies are expected to retain ... that are do not require rabbit pyrogen testing along ...
(Date:11/30/2016)... 30, 2016  Tempus, a technology company focused ... Penn,s Abramson Cancer Center have partnered to better ... to immunotherapy treatment based on next generation genomic ... of a research collaboration, Tempus will provide sequencing ... patient data to Penn. Utilizing next-generation sequencing, machine ...
(Date:11/30/2016)... IN (PRWEB) , ... November 30, 2016 , ... SSCI, ... experts to discuss the implications of the latest FDA guidance on pharmaceutical cocrystals ... 8, 2016 in Cambridge, MA. , The event follows the successful November ...
Breaking Biology Technology:
(Date:11/30/2016)... and WARSAW, Poland , Nov. 30, 2016 ... is one of the most crucial aspects of recovery so we need to do ... serious health risks, including heart problems, high blood pressure, stroke, diabetes, and even cancer. ... friends sleep and find a Christmas present that could help them to manage their ... ...
(Date:11/28/2016)... "The biometric system market projected to ... system market is in the growth stage and is ... biometric system market is expected to be valued at ... 16.79% between 2016 and 2022. Government initiative in adoption ... rising use of biometric technology in financial institutes and ...
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, a ... for public safety, investigation, corrections and monitoring, announced today ... competitor, ICSolutions, to have an independent technology judge determine ... most modern high tech/sophisticated telephone calling platform, and the ... that they do most of what we do – ...
Breaking Biology News(10 mins):